Management ChangeApr 30, 2026, 04:34 PM
ACHV Appoints Andrew Goldberg CEO; Adds TPG, venBio Directors
AI Summary
ACHIEVE LIFE SCIENCES, INC. announced significant leadership changes, including the appointment of Andrew D. Goldberg, M.D. as Chief Executive Officer and President, effective April 2026. The company also added Lucian Iancovici and Aaron Royston to its Board of Directors, effective April 17, 2026, following their designation by TPG Life Sciences Innovations and venBio Partners, respectively, after a recent private placement. Other key executive appointments include a new Chief Legal Officer, Chief Operations Officer, Chief Financial Officer, Chief Medical Officer, and Chief Commercial Officer.
Key Highlights
- Andrew D. Goldberg appointed CEO and President, effective April 2026.
- Lucian Iancovici (TPG) appointed Director, effective April 17, 2026.
- Aaron Royston (venBio) appointed Director, effective April 17, 2026.
- Erik Atkisson appointed Chief Legal Officer since October 2025.
- Craig Donnelly appointed Chief Operations Officer since September 2025.
- Mark Oki appointed Chief Financial Officer since December 2024.
- Mark L. Rubinstein appointed Chief Medical Officer since October 2025.
- Jaime Xinos appointed Chief Commercial Officer since October 2024.
Price Impact
More from ACHV